# FDA Inspection 1129378 - Jeremy Abramson MD - September 04, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/jeremy-abramson-md/9893b568-adda-4b0a-b872-81ffb929aa45
Source feed: FDA_Inspections

> FDA Inspection 1129378 for Jeremy Abramson MD on September 04, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1129378
- Company Name: Jeremy Abramson MD
- Inspection Date: 2020-09-04
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168775 - 2022-04-25](https://www.globalkeysolutions.net/records/fda_inspections/jeremy-abramson-md/ff93cc17-1723-46d5-902b-7af276b7fef4)
- [FDA Inspection 1129378 - 2020-09-04](https://www.globalkeysolutions.net/records/fda_inspections/jeremy-abramson-md/eb85dfb3-7096-44db-bb16-4c49a76669d0)

Company: https://www.globalkeysolutions.net/companies/jeremy-abramson-md/a8d57b4f-3d63-4865-9115-8213350d1448

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d